MedTrace Logo

Home And Locally Observed - Tracking (HALO-Trak)

NCT05971277 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-08-02

No results posted yet for this study

Summary

The goal of this observational study is to collect biometric, HRQoL, immune response and genomic data continuously and intermittently during and after chemo or immunotherapy for the generation of a complex dataset using a platform which can aggregate different types of data collected over a time period and, to test the potential for analysis within and across data sets with linkage to clinical outcomes. The framework will have capabilities to integrate data from electronic medical records (EMRs) such as Epic, as well as digital streams including sensor, genomic, imaging and pathology. Such a platform can realise the potential for machine learning (ML) methodologies to address important cancer outcomes.

Conditions

Interventions

DEVICE

Halo Wearable data device

A wrist-worn tracker with heart-rate monitor and pedometer (step counter), as well as a mobile app.

Sponsors & Collaborators

  • University College, London

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2025-04-01
Completion
2026-04-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05971277 on ClinicalTrials.gov